Gamified Occupational Therapy for Adolescents with Duchenne Muscular Dystrophy
Launched by BAŞAK ÇAĞLA ARSLAN · May 3, 2024
Trial Information
Current as of June 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of occupational therapy for young boys with Duchenne muscular dystrophy, a condition that affects muscle strength and movement. The researchers want to see if using fun, game-like activities (called gamification) can improve the daily lives, emotional health, and overall satisfaction of these young people compared to traditional therapy methods. This approach aims to find better ways to support adolescents with this condition.
To participate in the trial, boys aged 4 to 18 who have been diagnosed with Duchenne muscular dystrophy can apply, as long as they can read and write in Turkish and have a computer or tablet with internet access. Parents must agree to their child's participation and sign a consent form. Participants will engage in activities that are both enjoyable and therapeutic, helping them improve their skills and well-being. It’s a great opportunity to contribute to research that may lead to better treatments for Duchenne muscular dystrophy in the future.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Being diagnosed with Duchenne muscular dystrophy
- • To be literate in Turkish
- • To have scored 27 points or more on the Modified Mini Mental Test
- • Having a computer, tablet and internet connection
- • Volunteering to participate in the study by their parents and reading and signing the informed consent form
- Exclusion Criteria:
- • Having a neurological disease other than Duchenne muscular dystrophy and/or another diagnosed neurological disease accompanying Duchenne muscular dystrophy
- • Having a cooperation problem that prevents completing the assessments for any reason
- • Difficulty understanding and speaking the Turkish language
About Başak çağla Arslan
Başak Çağla Arslan is a dedicated clinical trial sponsor specializing in innovative research and development within the healthcare sector. With a commitment to advancing medical science, the organization focuses on conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory requirements. Leveraging a collaborative approach with healthcare professionals, researchers, and regulatory bodies, Başak Çağla Arslan aims to facilitate the development of novel therapies and improve patient outcomes through evidence-based practices. Their expertise encompasses a wide range of therapeutic areas, ensuring a comprehensive understanding of the complexities involved in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported